NYSE:WSTLife Sciences
West (WST) Stock Looks Fair On Cash Flow Yet Pricey On Earnings
West Pharmaceutical Services has delivered a 64.1% return over the past year, and after that kind of run the stock no longer looks obviously cheap, especially with most of the valuation checks leaning toward a premium price tag. The Discounted Cash Flow (DCF) intrinsic value estimate points to a roughly fair valuation, while market based multiples suggest the shares are priced on the rich side.
West Pharmaceutical Services' 64.1% 1 year return puts recent momentum front and center, which can...